```html

Viral Upper Respiratory Infection (Common Cold)

Overview

A viral upper respiratory infection (URI), commonly known as the common cold, is an acute infection of the nose, sinuses, pharynx, or larynx caused by a wide variety of viruses. It is the most frequent illness affecting humans.

• Who it affects: Almost everyone will experience at least one cold each year. Children under 5 have the highest incidence—averaging 6–8 colds per year—while adults typically have 2–3.
• Prevalence: In the United States, adults miss an average of 2.5 workdays per year due to colds, amounting to >200 million missed workdays annually <sup>[1]</sup>. Globally, the World Health Organization estimates >1 billion cases each year.
• Seasonality: Colds peak in colder months (November‑March in the Northern Hemisphere) but can occur year‑round.

Symptoms

Symptoms usually develop 1–3 days after exposure and last 7‑10 days. They vary in intensity, and most people experience a combination of the following:

Upper‑airway symptoms

• Nasopharyngeal congestion – a feeling of stuffiness or blockage.
• Rhinorrhea – clear, watery discharge that may become thicker and yellow‑green after 3‑4 days.
• Sneezing – frequent, often the first symptom.
• Itchy or watery eyes – due to irritation of the mucous membranes.

Throat‑related symptoms

• Sore throat – raw, scratchy feeling, usually mild and improves within a few days.
• Hoarseness – temporary change in voice.

Systemic symptoms

• Low‑grade fever – more common in children (up to 38.5 °C/101 °F); adults often stay afebrile.
• Headache – sinus pressure or tension‑type.
• Fatigue and malaise – feeling unusually sleepy or weak.
• Myalgia – mild muscle aches.

Less common / atypical features

• Ear pressure or mild otalgia (due to eustachian tube blockage).
• Loss of appetite, especially in children.
• Post‑nasal drip causing cough that worsens at night.

Causes and Risk Factors

The common cold is caused by more than 200 different viruses. The most common culprits are:

• Rhinoviruses – responsible for ~30‑50 % of cases.
• Coronaviruses (non‑SARS‑CoV‑2 strains) – ≈10‑15 %.
• Respiratory syncytial virus (RSV), adenovirus, parainfluenza, and human metapneumovirus.

How the viruses spread

• Aerosol droplets from coughing or sneezing.
• Direct contact – shaking hands, touching surfaces, then touching the face (nose, mouth, eyes).
• Fomites – contaminated objects such as phones, door handles, or toys.

Risk factors that increase susceptibility

• Age: Young children have immature immune systems; the elderly have waning immunity.
• Close‑quarters environments: Schools, daycare centers, nursing homes, and public transport.
• Smoking or exposure to tobacco smoke – damages nasal mucosa and impairs clearance.
• Immunocompromise: HIV, chemotherapy, transplant medications, or chronic diseases (e.g., diabetes).
• Seasonal factors: Low humidity and colder temperatures promote viral stability.

Diagnosis

In most cases, a clinical diagnosis based on history and physical examination is sufficient. No laboratory testing is required for typical colds.

Clinical evaluation

• History: Recent exposure, symptom onset, and progression.
• Physical exam: Nasal mucosal erythema, clear discharge, mild pharyngeal erythema, intact lung sounds (no wheezes or crackles).

When additional tests are considered

• Rapid antigen or PCR tests if influenza, RSV, or COVID‑19 is suspected (especially during flu season or if symptoms are severe).
• Complete blood count (CBC) only if bacterial infection is a concern (elevated white blood cell count).
• Chest X‑ray if lower‑respiratory involvement (e.g., pneumonia) is suspected.

Treatment Options

Since the infection is viral, antibiotics are ineffective and should not be used unless a secondary bacterial infection is confirmed.

Pharmacologic measures

• Analgesics/Antipyretics: Acetaminophen or ibuprofen can reduce fever, headache, and sore throat.
• Decongestants: Oral pseudoephedrine or topical oxymetazoline (max 3 days) relieve nasal congestion.
• Antihistamines: First‑generation (diphenhydramine) may reduce rhinorrhea; second‑generation (loratadine) are less sedating.
• Cough suppressants: Dextromethoran for dry cough; expectorants (guaifenesin) for productive cough.
• Topical saline irrigation: Isotonic saline spray or neti pot helps clear mucus and improves comfort.

Procedural / supportive care

• Humidified air: Using a cool‑mist humidifier or taking steamy showers eases mucosal dryness.
• Throat lozenges or honey: Provide symptomatic relief for cough and sore throat (avoid honey in children <1 yr).

Lifestyle and non‑pharmacologic measures

• Rest: Allows the immune system to focus on viral clearance.
• Hydration: ≥8 cups of fluid daily (water, broth, herbal tea) thins secretions.
• Nutrition: Balanced diet rich in fruits, vegetables, and protein supports immunity.

Living with Viral Upper Respiratory Infection (Common Cold)

Most people recover fully without complications. The following daily‑management tips can reduce discomfort and speed recovery:

• Stay home: Limit contact with coworkers, schoolmates, and vulnerable individuals while symptomatic.
• Hand hygiene: Wash hands with soap for ≥20 seconds or use an alcohol‑based sanitizer after coughing, blowing the nose, or touching surfaces.
• Nasal care: Perform gentle saline rinses 2–3 times daily; avoid excessive blowing which can irritate nasal lining.
• Sleep: Aim for 7‑9 hours for adults, more for children; pro‑inflamatory cytokines are cleared during deep sleep.
• Temperature control: Keep indoor humidity between 40‑60 % to reduce viral survival.
• Monitor symptoms: Keep a symptom diary; note any worsening (e.g., high fever >38.5 °C lasting >3 days, new chest pain).

Prevention

Because the common cold is highly contagious, multiple layers of protection are most effective.

Personal hygiene

• Wash hands frequently, especially after being in public places.
• Avoid touching the face with unwashed hands.
• Cover mouth and nose with a tissue or elbow when coughing/sneezing; discard tissue immediately.

Environmental measures

• Disinfect high‑touch surfaces (doorknobs, phones) daily with EPA‑approved cleaners.
• Use air purifiers with HEPA filters in crowded indoor settings.
• Maintain adequate indoor humidity (40‑60 %).

Vaccination & prophylaxis

• While there is no vaccine for the common cold, annual influenza vaccination reduces the overall burden of respiratory illness and helps differentiate flu from a cold.
• COVID‑19 vaccination, especially booster doses, prevents co‑infection that can worsen outcomes.

Lifestyle strategies

• Quit smoking and limit exposure to second‑hand smoke.
• Regular moderate exercise (150 min/week) has been shown to enhance mucosal immunity.
• Manage stress; chronic stress impairs immune response.

Complications

Although the common cold is usually self‑limited, complications can arise, particularly in high‑risk groups.

• Acute bacterial sinusitis: Persistent facial pain, thick purulent nasal discharge, or fever >10 days.
• Acute otitis media: Ear pain, hearing loss in children.
• Exacerbation of asthma or chronic obstructive pulmonary disease (COPD): Increased wheezing, shortness of breath.
• Pneumonia: Usually bacterial superinfection; presents with high fever, productive cough, chest pain.
• Secondary bacterial lower‑respiratory infection: Particularly in the elderly or immunocompromised.

Prompt medical evaluation is needed if any of these develop.

When to Seek Emergency Care

References

1. Mayo Clinic. “Common cold.” Updated 2024. https://www.mayoclinic.org
2. CDC. “Common Cold.” 2023. https://www.cdc.gov
3. NIH National Institute of Allergy and Infectious Diseases. “Respiratory Viruses.” 2024. https://www.niaid.nih.gov
4. World Health Organization. “Acute Respiratory Infections.” 2022. https://www.who.int
5. Cleveland Clinic. “Cold vs. Flu.” 2024. https://my.clevelandclinic.org
6. Jena AB, et al. “Economic Burden of the Common Cold.” JAMA Internal Medicine. 2023;183(9):1023‑1030.

```